Status:
UNKNOWN
Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial
Lead Sponsor:
University Hospital, Rouen
Conditions:
Autoimmune Diseases
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Pemphigus is an autoimmune disease specific to the skin and mucous membranes characterized by the production of IgG4 isotype autoantibodies (AC) directed mainly against two proteins involved in interk...
Eligibility Criteria
Inclusion
- Patient included in the RITUXIMAB 3 study
- Major patient who has read and understood the newsletter and signed the consent form
Exclusion
- Person deprived of liberty by an administrative or judicial decision
- Person placed under the safeguard of justice
- Person under tutorship or curators
- Pregnant or lactating woman
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03790293
Start Date
December 1 2019
End Date
December 1 2019
Last Update
December 31 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.